Crea il mio profilo
Accesso pubblico
Visualizza tutto67 articoli
2 articoli
Disponibili
Non disponibili
In base ai mandati di finanziamento
Coautori
- Nicholas P Restifo, MDCellular Immunotherapy ExplorerEmail verificata su marbletx.com
- Steven A RosenbergNCIEmail verificata su nih.gov
- Luca GattinoniLeibniz Institute for Immunotherapy (LIT)Email verificata su lit.eu
- toren finkelUniversity of PittsburghEmail verificata su pitt.edu
- Alena GrosVall d'Hebron Institute of OncologyEmail verificata su vhio.net
- Gautam MehtaFDA OncologyEmail verificata su fda.hhs.gov
- Luis Sanchez-PerezTune TherapeuticsEmail verificata su duke.edu
- Klaus OkkenhaugDivision of Immunology, Department of Pathology, University of CambridgeEmail verificata su cam.ac.uk
- Mark E DudleyCSO, Instil BioEmail verificata su instilbio.com
- Nicholas KlemenNational Cancer InstituteEmail verificata su nih.gov
- Pós ZoltánAssistant Professor, Dept. Of Genetics, Cell and Immunobiology, Semmelweis UniversityEmail verificata su med.semmelweis-univ.hu
- Eric TranEarle A. Chiles Research Institute, Providence Cancer CenterEmail verificata su providence.org
- suman mitraPrincipal investigator, Univ. Lille, CANTHER, CNRS 9020, INSERM UMR 1277, CHU Lille,Email verificata su inserm.fr
- Jason A. HallAbbVieEmail verificata su abbvie.com
- Rongman CaiNIHEmail verificata su nih.gov
- Sean SpencerStanford UniversityEmail verificata su stanford.edu
- Lukas FlatzUniversity of Tübingen (Medical Faculty)Email verificata su med.uni-tuebingen.de
- CAstraZeneca
Segui
Christopher A. Klebanoff, M.D.
Associate Member, Memorial Sloan Kettering Cancer Center
Email verificata su mskcc.org